Get started

Undervalued

Silver is a Screaming BuyAll long-looking indicators point to silver being undervalued vs gold. Top chart shows silver candlesticks vs gold red line as percentage returns since 1998. Middle indicator is the Trader's Dynamic Index (TDI) which holds a combination of moving average, volatility and momentum trends. Bottom indicator is the infamous Gold:Silver ratio. Silver is sitting on top of the .382 fib level support shown in the chart, which is where the current cost of production resides around $14.75/oz. Low risk, high reward - this is a perfect setup for those interested in making an inflation play going toward negative rates, QE4 and the end of the petrodollar. % Returns Analysis: Silver below Gold -> Silver undervalued Fibonacci Level: Strong support at cost of production near $14.75/oz TDI: Bullish divergence in formation Gold/Silver ratio: 83:1 -> Silver undervalued
TVC:SILVERLong
by Derivati_Capital
1
$CMPY: This past +30% winner just signed a deal w/ Tech Giant...===================== CMPY (Comepay Inc.) Alert Price: $4.30 Float: 476.342K Chart Analysis ======================== Members, It's only Tuesday, and our trade ideas have already delivered as much as +187% in long-term profit! For our next trade idea, we are revisiting one of our biggest winners of Q1 2019. Please turn your immediate attention to CMPY (Comepay Inc.). The last time we brought CMPY to your attention, shares of this up-and-coming payment solutions provider rallied over +31% from $4.00 to a high of $5.25! Shares of CMPY have since pulled back to a much more attractive entry price of $4.30, but we believe its next run past $5.00 could start as early as tomorrow. Here's why... CMPY has recently added tech industry giant Asus to its already impressive client list, which includes automotive giant Volvo, and industrial juggernaut Bosch. It's not often you see multi-billion dollar market cap companies sign contracts with little known companies like CMPY. This leads us to believe that CMPY's technology is best in breed, and that the Company itself is undervalued at the moment! It's no surprise that CMPY's management plans to uplist the Company this year, If you didn't know already, CMPY operates in one of the most lucrative sectors on Wall St., with companies like Square Inc. delivering over +175% in returns within the last year. Currently trading at $4.30 per share, we believe that CMPY shows traders much more upside potential than the bigger names in this sector. This has the potential to be one of our biggest winners of Q1 2019. If you missed out on CMPY's previous +31% run, you may want to consider jumping on board this time around. That being said, we are urging all members to read our full profile, start their research now, and consider grabbing up a position in CMPY tomorrow morning at 9:30AM EST! About Comepay The Comepay group of companies including Comepay, RP Systems, M-NN LLC and Chek-online have been operating for over 11 years providing internet acquiring services and support, facilitating instant payments and internet-based payment transactions via kiosks, mobile interfaces and web-based applications such as electronic wallets. The Company also leases and sells cash registers and Point of Sale (POS) systems, including its recently developed proprietary multifunctional smart POS fiscal cash register system. Combining proprietary software and equipment, Comepay processes over 10 million customer payments per month and presently has more than 22,000 kiosks across Russia. The companies are currently focusing their planned business expansion on the smart POS fiscal cash register system called “Cassatka” in order to help businesses comply with newly released Russian taxation legislation, 54-FZ which requires 1.2 million businesses in fiscal 2018, and a further 1.4 million businesses in fiscal 2019 to install new, federally compliant on-line cash registers. The Cassatka, Comepay’s multifunctional smart POS online fiscal cash register can process payments and meet fiscal data storage requirements for participating businesses. It is a convenient and cost competitive solution for businesses to meet the new federal taxation requirements in Russia, and is currently being manufactured for distribution prior to June 2018. As the companies expand their business model, we expect to offer blockchain acquiring services and also to accept payments in multiple crypto currencies on the Cassatka. The Comepay group of companies presently earn revenue from a variety of channels including fee based commissions on payment processing for both cash and debit card payments, software licensing, kiosk placement fees and other rental fees for cash registers and associated equipment. The Comepay companies are looking to expand rapidly in fiscal 2018 and beyond as we introduce and market the Cassatka along with a suite of enhanced user features. Please see websites below: www.comepaygroup.com, www.comepay.ru, www.Cassatka.me, www.chekonline.ru, www.starrys.ru Bullish Catalysts for CMPY Added Asus as its newest customer in order to bring their online store compliant with Russian Federal Law 54, requiring businesses and individuals to use federally compliant cash registers, including a fiscal chip for processing sales transactions. CMPY has been one of the market's top performing publicly trading companies, with shares up over 1,333% over the last 52-weeks! Based on our very own chart analysis, we see the realistic potential for a +128% move. Processes over 10 million customer payments per month and presently has more than 22,000 kiosks across Russia. Added increased functionality to its smart terminals including the Unified State Automated Information System (“USAIS”) app, in order to simplify reporting of alcoholic beverages and products to the Federal Tax Authority of the Russian Federation, including the ability to issue industry compliant receipts for alcoholic products sold. Upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets. Chek-online development staff are yet to disclose the name of the app and its exact release date, but expect the app to be launched no later than May of 2019. Recently signed up Volvo (Russia) for provision of stationary smart terminal units located inside its data centers in Russia. Entered into a lease agreement with Bosch, a global market leader in electronics and engineering, for provision of stationary smart terminal units located inside its data centers in Russia. Upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets. Partnership with Russian retail bank, Post Bank, for purchase and sale of the Cassatka, their fully compliant smart terminal cash register line to meet fiscal compliance legislation across Russia. The Company has plans to uplist this year. 5 Reasons Why We Think CMPY Needs to be on Top of Your Watchlist THE RIGHT SPACE How are tech stocks in the market looking? Wall Street will tell you it’s the hottest investment market in a decade. It’s on fire, literally and figuratively. INNOVATIVE PRODUCTS CMPY is all about the payments.CMPY uses tech to make payments easier and more efficient. We believe this provides investors a unique opportunity to acquire an interest in an upcoming tech company that could be a leader in the payment industry. UNDER THE RADAR Being new to the market and hovering under the radar of Wall Street, we believe CMPY is attractive in comparison to its peers. And up until now, one of the best-kept secrets. MASSIVE GROWTH POTENTIAL The market opportunity for CMPY is HUGE! Comepay could take the mobile payment markets by storm. THE BEST AND THE BRIGHTEST Boasting a “top-tier technology that is unmatched in the industry”, the CMPY provides a one-stop source for everything payment related. Recent Developments IS CMPY GOING TO REVOLUTIONIZE ONLINE PAYMENTS? Comepay, Inc. (CMPY) (“the Company”) is pleased to announce that its wholly owned subsidiary Chek-Online LLC, a leading manufacturer of fiscal cash registers in Russia, and developer of the family of Cassatka smart terminals has disclosed the upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets. Chek-online development staff are yet to disclose the name of the app and its exact release date, but expect the app to be launched no later than May of 2019. The mobile app is designed to allow all users who have downloaded the platform to easily find outlets that use the Cassatka online cash terminal: view all available products, compare prices, receive discounts and immediately place orders for delivery to any location in the city, paying remotely using their bankcard. The seller, in turn, will receive a notification about the online order on their Cassatka smart terminal, and will be able to process the order for delivery. The details of the products featured on the app will be made available using the built-in accounting system provided with the fiscal cash register. Business owners can update their back end system in order for the app to provide details such as products for sale, number of units in stock, price and available discounts. All information provided in the app is automatically synchronized with the individual login account for the business owner and transferred to the app. Data transferred to the app is available for download by any interested consumer. Currently, more than 20,000 individual businesses across Russia are selling their products and processing payments using our series of Cassatka online cash registers, with new users being added on a daily basis. According to the Chek-online development team, this app is intended to establish a direct connection between the seller and the buyer, creating a comfortable environment for online. The app is also intended to drive potential customers to mobile storefronts and encourage online trade. It was important to the Chek-online development team that users can compare both like products from storefronts in the same product category, as well as other product categories. As a result, potential customers are able to create a multi-category basket in the app pulling product from different stores into one easy to use comparison and purchase process. The app is designed to provide all the advantages and benefits that come with other online shopping providers. Customers will easily be able to access the necessary information about the products in order to quickly and efficiently be able to make an informed decision about online purchases. Market Outlook Global payments revenues swelled to $1.9 trillion in 2017, the best single year of growth in the last five years. The Asia–Pacific region, including China—which currently accounts for the largest share of payments revenues (40 percent)—will continue to be the engine of growth. It will comprise 56 percent of the global increase in revenues during the next five years, with China alone accounting for 40 percent of the global increase. However, Western Europe and developed Asia, where growth rates have been negative in recent years, will also rebound. Cross-border payments and trade finance will benefit in the coming years as well, driven by the strong recovery expected in trade flows (which have a projected compound annual growth rate of 8 percent from 2013 to 2018). This return to strong growth is being fueled primarily by sustainable volume increases, rather than less sustainable improvements in revenue margins, for both liquidity revenues (net interest income on liquid assets and deposits2 ) and transactional revenues (fee and float income on payments transactions). Indeed, margin improvement will barely contribute to the $410 billion increase in liquidity revenues between 2013 and 2018. Transactional revenues will increase by $340 billion by 2018 due to higher transaction volumes, despite the dampening effects of more regulation and competition. Technical Analysis We love alerting these past winners because we already have a good idea of their trading behavior. From what we see right now, CMPY appears to be primed and ready to break through its $5.00 resistance. Based on our very own chart analysis, we see the realistic potential for a +128% move. With its low-float of 476,342K, CMPY appears to move on air! On December 27th, we saw its share price nearly double on light volume! We've already watched CMPY tick up over +31% in just a few days time. If you missed out on CMPY's previous +31% run, you may want to consider jumping on board this time around. This has the potential to be one of our biggest winners of Q1 2019! As such, we are urging all members to start their research now, and consider grabbing up a position in CMPY tomorrow morning at 9:30AM EST! (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated twelve thousand five hunded dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for CMPY. We have been previously compensated ten thousand dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for CMPY- which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
OTC:CMPYLong
by RedHotStocks
NWGFF is our new cannabis breakout pick. See why a +60pct move..===================== NWGFF New Age Brands Inc. Alert Price: $0.0478 Chart Analysis ======================== Members, Are you ready to kickoff the month of February with a bang? For our next trade idea, we are focusing on a red-hot sector that has proven highly profitable for our members time and time again. That's right, it's time for another cannabis play... Please turn your full attention to NWGFF (New Age Brands Inc.). After witnessing a downtrend the past few months, NWGFF appears to have finally bottom'd out. NWGFF has been quietly building up momentum, and is now showing signs of a highly profitable bullish reversal in the making Shares of NWGFF closed up over +17% today, while trading on higher than average volume, and we are feeling confident that another double-digit move is in store for NWGFF tomorrow. There's a strong change that today's double-digit move caught the Street's attention, so don't be surprised if we see a move past $0.05 early tomorrow! If you look at NWGFF's 1-year chart, you will see that the last time we saw this particular setup, shares rallied +200% from $0.04 all the way to $0.12! NWGFF appears to be grossly oversold and undervalued at these levels, especially when you take into account the growth initiatives their management has made over the past few months. The Company has made several market friendly announcements as of late, all of which could be considered bullish catalysts as we head into Q1 2019. MassRoots, Inc. a leading technology and rewards platform, signed an agreement with NWGFF subsidiary, We are Kured, LLC, to serve as a leading online retailer of the Company's #1 best-selling CBD Pen.* Wholly owned subsidiary, We Are Kured, LLC (“Kured”), plans to launch a new vape option for their broad spectrum 48% CBD oil. Although their main product offering will be the current 500mg disposable vaporizing pen, this new vaporizing cartridge will help round out KURED’s product line. We Are Kured, LLC’s Pineapple Express vape pen is the top selling vape pen at the iconic Native Roots Wellness CBD store in Denver, Colorado. The success of the vape product in the leading CBD market in Denver, one of the most advanced in the country, is helping to increase awareness of both the Company and the benefits of the new and burgeoning CBD market for consumers and investors. Entered into a “Drop Ship” agreement with The Grown Depot with respect to their two fully owned subsidiaries, We Are Kured, LLC and Drink Fresh Water LLC. Under the terms of the agreement, The Grown Depot will sell the Company’s products through their website (www.TheGrownDepot.com) while the Company will facilitate the shipment of orders through their Denver, Colorado warehouse. Secured an order of its wholly owned subsidiary’s Fresh Water CBD product with Colorado’s largest liquor store, Argonaut Liquors, located on Colfax in downtown Denver. Argonaut Liquors, a historical Denver staple liquor store, is seeing the momentum of CBD water and wants to be ahead of the competition by offering Fresh Water CBD to their 21+ clientele. As you can see, the management at NWGFF is taking a highly aggressive approach in increasing brand awareness. The Company's CBD Pen is a hit already, and its only a matter of time until we see its effect on NWGFF's bottom line. In addition to having a top selling product, NWGFF is also very attractive from a technical standpoint. Based on our very own chart analysis, we see the potential for a move of +60%! We know it has already been a highly profitable week/month for our members, but we believe NWGFF could add a significant amount to that already impressive gains total. That being said, we ask that all members read our full profile, start their research now, and consider grabbing up a position in NWGFF tomorrow morning at 9:30AM EST! About New Age Brands Inc. New Age Brands is an innovative Cannabidiol ("CBD") lifestyle Company. Through the Company's wholly owned subsidiaries We are Kured and Drink Fresh Water, the Company's main business activities encompass the development, marketing and distribution of CBD products (including vaporizer pens and beverages) throughout the United States and internationally. In addition, New Age Brands has extensive retail and cultivation land investments in Oregon. About We Are Kured, LLC KURED is a wholly owned subsidiary of New Age Brands, acquired in December 2017. KURED is building an innovative online CBD and lifestyle company. KURED has partnered with best in class hemp cultivators, edible manufacturers, cutting edge product formulators to develop, market and distribute multiple lines of CBD products including, but not limited to, CBD vaporizer pens, topicals, gel capsules and more. All of We Are Kured's products are 100% THC free and will be available for purchase internationally. THC, or tetrahydrocannabinol, is the primary active ingredient in cannabis. NWGFF is growing quickly in the Cannabis industry, and it's doing so by focusing on the fundamentals. The Denver-based company is meticulously carving out its share of the emerging hemp and CBD markets in the U.S., Canada and South America. And, in the process, it's providing the cannabis space with more choices while offering investors an opportunity to get in on the ground floor of an ever-expanding company. First and foremost, to understand more about New Age Brands , we have to understand the markets within the cannabis industry that they've chosen to call home—the Hemp and CBD markets. Hemp is the fiber and seed part, and the most valuable part of the Cannabis plant, which is why hemp is often called a "cash crop." Meanwhile, CBD or cannabidiol is a naturally occurring cannabinoid in hemp that has significant medicinal benefits without the psychoactivity of THC. CBD is an appealing option for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and a host of other conditions. So how has New Age Brand's management chosen to create what it feels will be a successful footprint in the cannabis industry? Well, while many smaller companies use lots of press releases and promises of great things to come to attract investors, executives at New Age Brands are actually building the company fundamentally with: Acquisitions that make up a growing portfolio of revenue-producing companies already operating in the CBD/hemp space A number of property assets in Washington State and Oregon The expansion of its footprint into markets that provide a sustainable operating environment and allow New Age Brands to maintain its goal of becoming a worldwide "brand." With continued success in these three areas of growth, this small company's future in a burgeoning industry looks very attractive. When asked about New Age Brand's focus moving forward, management said that it has decided to move its attention and resources into acquiring already proven business entities and businesses that it feels have strong growth potential and strong core management in the hemp and CBD space. Additionally, the company says it's currently working with a number of science teams to develop innovative products that New Age Brands is confident can accompany its growing portfolio while also standing out on their own in the industry. Currently, New Age Brands has two subsidiaries that it recently acquired: We Are Kured or "Kured" (www.wearekured.com) and Drink Fresh Water (www.drinkfreshcbd.com). Both companies are generating revenue with the sale of products in the hemp and CBD industries. Through its subsidiary, Kured, New Age Brands is building an innovative online CBD and lifestyle company. Kured has partnered with best-in-class hemp cultivators, edible manufacturers, and cutting edge product formulators to develop, market and distribute a number of CBD products. In addition to filling orders in the U.S. and Canada, Kured recently expanded into South America where it plans to distribute products throughout the region with "Kured Latin America LLC." Its other subsidiary, Drink Fresh Water, is a California-based company created by a group of industry leaders that offers New Age Brands immediate entry into the CBD-infused beverage industry with its flagship product, "Fresh Water." The CBD-infused, nano-amplified alkaline water can be found in retail stores in 35 different states across the U.S., and with the drink's success, management has already expressed that it expects to expand the company's lineup of products by adding additional SKUs in the near future. New Age Brands is also growing a portfolio of properties that are proving to be revenue-producing assets for the company as well. Management at New Age Brands says they look to acquire properties that have strong, proven and permitted operating tenants, and if the company chooses to acquire a property, they will implement their industry-leading expertise to optimize the potential revenue and overall net profit with that asset. The company says the properties it recently acquired in Oregon have already proven to be a great acquisition that they were able to take advantage of, while they're still evaluating the properties the company owns in Washington State to decide the best course of action for these properties. New Age Brands acts as the "landlord" of the two properties it acquired in Oregon—the Cave Junction, Oregon, property and the Portland, Oregon, property where New Age Brands generates almost $250,000 annually in rent payments alone. A state of the art outdoor and greenhouse cannabis cultivation facility is operated by Trellis Farms on the company's Cave Junction property, and the Portland property has been home to an established dispensary for the last four years. New Age Brands has laid out a plan that, so far, management has done a great job of sticking to, while being flexible enough to expand upon that plan when necessary. Its expansion into Latin America is one such example of the company not being afraid to grow where they feel there is a sustainable operating environment. Executives at New Age Brands feel that due to the uniqueness of the company's focus on hemp, regardless of being housed in the United States, they are not hand cuffed to the same onerous and expensive state-by-state marijuana licensing laws. Simply put management sees New Age Brands as a global brand. The company feels strongly that the wave of the future is in the hemp derived CBD market, and they will be building a plethora of brands to gain as much market share as possible in the industry. When asked to offer a report card of sorts on the plan that management has put into place, we were told that Kured is growing at a faster pace than they expected with profit margins increasing by 100 percent with its in-house manufacturing. The newly acquired Oregon properties are a great monthly revenue addition. Fresh Water is already in 35 states and by adding its own team's expertise, they are hopeful to be generating sales of Fresh Water on 2 continents by the end of 2018. The company says they're in talks with other existing CBD brands to potentially acquire, and New Age Brands also has ideas for its own CBD brands, which it says will be first to market. Market Outlook The cannabis market has grown at a tremendous pace over the recent years and as such, the industry has established itself a major global market. According to data compiled by Grand View Research, the global legal cannabis market is projected to reach USD 146.4 Billion by the 2025. It is also expected to grow at a CAGR of 34.6%. The market itself is witnessing a widespread legalization movement due to the growing adoption of the plant within the medical sector. Cannabis is being used heavily around the global for medical applications and treatments for maladies such as cancer, mental disorders, chronic pain, and others. However, the recreational market is thriving as well due specifically to the U.S. and Canada. States like California, Colorado, and Nevada are expected to propel the recreational sector forward at an encouraging rate. The acceleration of research and development has led to new products within the market, enhancing consumer experiences. The research suggests that the industry is expecting strong exchanges of technological knowledge and information. Meanwhile, as countries like Canada, the U.S., Germany, and Australia lead the market in sales, countries like Israel are focusing on research and technology development to further expand within the industry. Additionally, there are various new forms of technology being introduced into the cannabis sector, such as virtual reality, payment solutions, and medical devices. "That's why we firmly believe that technology stands at the center of the industry's advancement and growth," said Ben Curren Chief Executive Officer of Green Bits, "This innovation will continue to generate market growth, improve public perception, protect public health and safety and enhance the implementation of state programs and regulations. Technical Analysis Those of you who love "buying the dip" should be licking your chops at NWGFF. The Company is down nearly +75% from its 52-week high of $0.184. That being said, NWGFF appears to have been building momentum over the past few days, and we believe a bullish reversal is just starting to take shape. A reversal all the way back to its 52-week high would net members gains of over +284%! We did our own chart analysis, and see the potential for a more realistic move of around +60%! No matter which way you slice it, NWGFF looks like the next potential double-digit winner in our book. As such, we are urging all members to start their research now, and consider grabbing up a position in NWGFF tomorrow morning at 9:30AM EST! (*Remember to use a basic Stop-Loss Order or more advanced Stop-limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated twelve thousand five hundred dollars by third party to conduct investor relations advertising and marketing for NWGFF. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
NLong
by RedHotStocks
AGHI: This past +156% winner looks ready to RUN WILD once again!===================== AGHI Agora Holdings Inc. Alert Price: $0.1195 Float: 29.48M Chart Analysis ======================== Members, It's already been a profitable week for us. Friday's pick QBIO continued its bullish reversal, hitting a high $2.43 today, making it a two-day +37% winner for our members. Our pick from January 8th, ANFI, also had a big day, hitting a high of $1.07, a gain of over +143% from our $0.44 alert price. Congrats to all those who took action on our buy calls, and secured the up to +180% in total profits that our alerts provided. Now we would like to focus our attention to a past triple-digit winner that appears to be back in the buy-zone, and ready for a bullish reversal of its own. Please turn your immediate attention to AGHI (Agora Holdings Inc.). The last time we brought this highly diversified entertainment and media enterprise company to your attention shares were trading at nearly the exact same price as they are right now. Within 3-weeks time, shares of AGHI had more than doubled from our alert price to the tune of over +156% in multi-day gains. We have been keeping a close eye on this ticker ever since then, and now could be the perfect time to once again start building a position AGHI. Today, AGHI closed under 12-cents for the first time this year! This could be the perfect entry point for traders looking to cash in on what could be a highly profitable bullish reversal in the making. The Company has made several big announcements since we've last covered it, all of which could be considered bullish catalysts heading into Q1 2019. Announced the December 2018 appointment of Mr. Oleksandr Bondarenko, 11.24% shareholder of the Company and 24.5% shareholder of the Company’s controlled Hong Kong based subsidiary, eSilkroad Network Limited, as the Company’s Chief Operating Officer. Its 51% owned subsidiary, eSilkroad Network Limited (“ESRL”), has completed the first round of landing page prototype testing with Kitsoft of Ukraine, and is moving to conclude second stage testing of a series of revised prototype pages which commenced mid-December, 2018. eSilkroad Network Limited, entered into a Letter of Intent with Beijing Nuozhou Technology Company Ltd., the creator of www.ono.chat, a blockchain social media platform with over 3.8 million users across the globe. In order to pursue a strategic partnership. At just $0.1195 per share, AGHI is trading at the lower-end of its 52-week price channel, and well off its 52-week high of $0.40. We've already witnessed AGHI's breakout potential. With an upside of over +234%, AGHI should be the top ticker on your watchlist. This was one of our biggest winners of 2018! Let's hope history repeats itself in 2019! That being said, we ask that all members read our full profile, start their research now, and consider grabbing up a position in AGHI tomorrow morning at 9:30AM EST! About Agora Holdings Inc. Agora Holdings Inc., together with its subsidiary Geegle Media and affiliates, is presently an entertainment and media enterprise. Agora Holdings Inc. brings together media and technology, driving innovation to enhance online entertainment in five business segments: media networks, TV, studio entertainment, consumer products and interactive media. Agora is seeking to expand its portfolio to include dynamic and interactive web-based networking platforms for global implementation. Divisions: Esilkroad Network Limited Esilkroad Network Limited and its subsidiary, eSilkroad of Ukraine, is a conceptual B2B platform that intends to make the interaction between businesses and non-profit organizations throughout the world faster, more effective, and less costly. eSilknet, the web-based platform under development by eSilkroad Network Limited will allow users to search for and communicate with business partners, search for and post proposals for investment and opportunity in developing projects globally, place advertisements for products and services, communicate securely on trade and project development and attract professional services for specific project-based needs. The concept of eSilknet is in line with the original concept of the “silkroad”, facilitating trade and commerce between countries, only a global scale. eSilkroad Network is currently negotiating the acquisition of complementary platform, “eSilktrade” which has been under development privately in Shanghai for several years. eSilkroad Network believes the combined expertise of its Ukraine based eSilkroad development team and the existing team at eSilktrade can integrate the live trade platform into its B2B site further enhancing value for its users. www.esilknet.com Software Development GEEGLE MEDIA Geegle Media’s project management is a value-driven approach that allows the company to deliver high-priority, high-quality work and look like rock stars to their stakeholders. Its nothing like the plodding, costly and error-prone approach to project management, which has delivered inconsistent results for years. Software projects change constantly. When customers are expected to finalize requirements before they can test-drive the prototypes, overhead and long delays often cripple the project. Geegle Media Management is about embracing change, even late in the development stage. It’s about delivering the features with the greatest business value first, and having the real-time information to tightly manage cost, time and scope. Geegle Media Project Management reduces complexity by breaking down the many-months-long cycle of building requirements for the whole project, building the entire product and then testing to find hundreds of product flaws. Instead small, usable segments of the software product are specified, developed and tested in manageable, two- to four-week cycles. Social Media/Marketing FLEET Takes Your social media campaigns to the next level! Frame gives You full control over Your social media campaigns Login using Facebook Login using Twitter Login using Instagram Manage all of Your social media channels in one place Schedule your posts for the right time Prepare your posts and prepare their share in the future. Save time and efforts. Publish posts on all social accounts you need. Generate professional infographic reports Use their analytic tools to generate professional presentations for social media performance in special designed templates Follow your best friends more intensive Follow what your social media friends upload and choose what posts to see Recent Developments Agora Holdings Inc. Subsidiary, eSilkroad Network Limited, Completes First Series of Prototype Testing and Commences Second Stage Testing Protocols, Implementing Feedback From Initial Test Group Results In late December, AGHI announced that further to our press announcement of December 3, 2018, its 51% owned subsidiary, eSilkroad Network Limited (“ESRL”), has completed the first round of landing page prototype testing with Kitsoft of Ukraine, and is moving to conclude second stage testing of a series of revised prototype pages which commenced mid-December, 2018. Between December 3 and December 10, 2018, a total of 87 companies from around the globe participated in our initial Unmoderated Remote Usability Testing (URUT) of over 30 key prototype pages for our developing B2B platform intended to make the interaction between businesses and non-profit organizations throughout the world faster, more effective, and less costly. Test participants provided feedback on various aspects of the prototype pages including concept, functionality and appeal. Our engaged operational partners, Kitsoft of Ukraine, and design partners, Rain Partners of Ukraine, received real-time test results and immediately implemented feedback from test participants in order to provide revised prototype pages for second round testing which commenced on the 13th of December 2018. The Company intends to carry out ongoing prototype testing and focus groups during the month of January 2019, ultimately exposing over 300 corporations to our landing page prototypes. eSilkroad Network’s technical director, Alexander Lobko, commented, “We were extremely pleased with the first round of test results for our innovative B2B social network, ‘eSilknet’. All process testing was completed in accordance with our original concept development and assessment protocol which allows for immediate implementation of test feedback so that we can quickly and efficiently move to each subsequent testing phase. We are looking forward to releasing more details of our test results as we complete each trial phase. Of the initial 87 corporate participants, over 65% were corporate entities from the People’s Republic of China. We expect the Chinese market to be a key userbase for our B2B network, opening trade and communication channels for Chinese corporations world-wide.” Market Outlook The social media market has been hot for the past few years. Companies have realized social media could be one of the main drivers of growth. However, with the Facebook scandal, it’s opened the market up for new competitors to join in on the action. According to Research and Markets, B2B e-commerce sales are forecast to be over two times higher than global online retail sales. That said, there is immense growth potential in the market. A report from Forrester Research in 2017 estimated business-to-business (B2B) ecommerce transactions would reach $1.2 trillion by 2021. Frost & Sullivan has even loftier expectations with B2B ecommerce hitting $6.6 trillion by 2020. Over 400,000 organizations are already shopping on Amazon Business with B2B. Technical Analysis As we enthusiastically stated above, AGHI has a well recorded history of breaking out for big gains. The last time we brought this ticker to your attention, shares ran-up over +156% in about 3-weeks time! More recently, on January 14th, shares of AGHI ran-up over +34% in a just a single-session. We've done our very own chart analysis, and see the potential for a move of +99%! If you've been following our newsletter, you know that we've been right on the money with all of our alerts this year so far. We are feeling confident that AGHI will be the next big mover for our members. As such, we are urging all members to start their research now, and consider grabbing up a position in AGHI tomorrow morning at 9:30AM EST! (*Remember to use a basic Stop-Loss Order or more advanced Stop-limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated twelve thousand five hundred dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for AGHI. We have been previously compensated ten thousand dollars by ACN LLC. to conduct investor relations advertising and marketing for AGHI -which has expired. We have been previously been compensated five thousand dollars by World Wide Holdings dba Invictus Resources to conduct investor relations advertising and marketing for ANFI -which has expired. We have been previously compensated ten thousand dollars by ACN LLC. to conduct investor relations advertising and marketing for QBIO-which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
ALong
by RedHotStocks
$QBIO is our New Low-float, BioTech Alert w/ MASSIVE UPSIDE!===================== QBIO (Q BioMed Inc.) Alert Price: $1.77 Float: 9.2M Investor Presentation Fact Sheet Shareholder Update Corporate Update Video ======================== Members, We hope you enjoyed the over +23% in realistic profit that Wednesday's alert provided. Earlier today, we told you that we had identified a company operating in the biotech space that looks primed and ready to breakout for some significant gains in the immediate future. Please turn your immediate attention to QBIO (Q BioMed Inc.). This biomedical acceleration and development company appears to be extremely undervalued and oversold at the moment, and we want our members to be on board for what we believe will be an epic bullish reversal in Q1 2019. The company has several bullish catalysts working in its favor that we believe will help make it a significant winner for our members: The biotech sector as a whole has been on fire, and is up over +20% since December 24th. Strong corporate leadership led by CEO Denis Coran. A growing pipeline and strategy that mitigates risk & drives shareholder value. Acquired the metastatic skeletal cancer palliation drug, Metastron™, from GE Healthcare.The agreement gives QBIO ownership of the brand, trademarks and market authorizations in 22 countries. In addition, all historical and current sales and distribution data related to those market authorisations will be assigned or transferred to QBIO to allow for as seamless a transition as possible in all markets. QBIO anticipates Metastron™ to start generating revenue in 1H 2019, with gross palliation revenue expected to be $20M-$40m p/a in year 3. QBIO's QBM-001 treatment for pediatric non-verbal disorder has $5B in global market potential. QBIO believes that it will complete formulation and manufacturing of QBM-001 by the end of the second quarter of 2019, after which it will file an investigational new drug (IND) application with the FDA. The company is hopeful that QBM-001 may receive the relevant designations from the FDA that could accelerate the development timeline. Assuming authorization from the FDA for the IND, the company believes it could begin a pivotal clinical trial of QBM-001 in the third quarter of 2019, which could lead to reviewed interim data as early as the first quarter of 2020. Now what has us really excited about QBIO, is what we heard during CEO Denis Coran's audio interview with SmallCapVoice.com on January 15th. At around the twelve minute mark, Mr. Coran hints at an upcoming FDA approval for QBIO's south Texas manufacturing facility. Once approved QBIO can start producing Metastron™ commercially for sale in the U.S. and then internationally! This drug is a substantial opportunity for QBIO. A very similar drug with a very narrow indication currently does almost $800 million a year in revenue! This would be huge news, and could have a major impact on QBIO's stock price. This is a great and informative interview, and it should get you excited about the incredible opportunity that QBIO presents you at the moment. We would also like to mention, that just like several of our past big winners, QBIO trades on the OTCQB Venture Marketplace. Securities trading on OTCQB have higher reporting and certification standards, which tends to lead to increased liquidity, investor confidence, as well as enhanced shareholder value. This has the potential to be our next big winner of Q1 2019. As such, we are urging all members to read our full profile, start their research now, and consider grabbing up a position in QBIO tomorrow morning at 9:30AM EST! About Q BioMed Q BioMed, Inc. is a biomedical acceleration and development company. They are focused on licensing and acquiring biomedical assets across the healthcare spectrum. Q BioMed is dedicated to providing these target assets the strategic resources, developmental support and expansion capital they need to meet their developmental potential so that they can provide products to patients in need. QBIO approaches biopharmaceutical development from a nontraditional angle. Rather than strictly devoting its resources to internal development, the company licenses what it deems to be undervalued biomedical assets in order to accelerate the achievement of clinical and commercial milestones. The company has five assets in its pipeline, led by its cancer palliation program, and diversified across multiple areas of significant medical need, including developmental nonverbal disorder, liver cancer and glaucoma. Q BioMed Unlocks Undiscovered Biomedical Value Targets assets entering validation, clinical stages or commercialization leading up to value creating inflection points Deploys performance-based capital and resources to accelerate the development of an asset milestone achievement by its management Licenses or acquires the assets and works together to create valuation growth How Q BioMed Accelerates Biomedical Technology Development Unlocks capital in US public markets to fund the development of assets Makes liquid investments in high-value assets that can produce exponential returns Diversifies risk over several therapies in various stages of development and deploys performance-based capital only Accelerates its asset’s development with management and advisory teams' expertise, experience, and industry relationships Recent Developments Q BioMed Adds Clinical Psychologist at Yale's Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001 On Wednesday, QBIO announced that Pamela Ventola Phd, from Yale University has joined its Advisory Committee for its QBM-001 clinical program. QBM-001 is being developed and tested for the treatment of minimally verbal or non-verbal toddlers with an Autism Spectrum Disorder (ASD). Dr. Ventola serves as a clinical psychologist and assistant professor at Yale University's Child Study Center with a clinical and research focus in: behavioral treatment for autism spectrum disorders, Pivotal Response Treatment (PRT), biological markers of treatment response, and dissemination and implementation of treatment for ASD. Dr. Ventola also directs the Rare Disease and Pediatric Center of Excellence at Cogstate, a publicly traded company that supports pharmaceutical companies in clinical trial design, methodologies, and rater training services as it relates to cognitive and other clinical outcome assessments. Strategy and Clinical Trial Design Specialist Provides Expertise for the Clinical Trial Design and Regulatory Requirements of QBM-001 QBM-001 Developed to Treat a Pediatric Non-Verbal Disorder which impacts 18,000 children each year in the U.S and a similar amount in Europe. Market Outlook The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022. Bone Metatases from Prostate and Breast Cancer 450,000 new breast and prostate cancer diagnoses each year 1 in 3 people will develop bone metastases from the spread of breast and prostate cancer Pediatric Non-Verbal Disorder Among the >60,000 US children who develop Autism Spectrum Disorders (ASD) every year, 20,000 become nonverbal and will have to rely on assisted living for the rest of their life. Liver Cancer 700,000 patients worldwide Short 1-year survival rate Estimated 39,230 adults in the US will be diagnosed every year Glaucoma 60 million patients worldwide 8 million with bilateral blindness Typically no early warning signs Therapy only slows progression, no cure Technical Analysis QBIO's stock price has been on a downtrend as of late, but we believe that the bottom is in, and that the upside potential far outweighs the downside risk. CEO Denis Coran addressed the stocks decline in his most recent shareholder update, and we feel confident that he and his management team are well on their way towards reversing this downtrend. QBIO is trading well off its 52-week high, with plenty of room to the upside. In fact, a run back to its 52-week high of $4.50 would represent a gain of over +154%! The float on QBIO is also very thin at just $1.77, so don't be surprised if we see a big move from this ticker tomorrow. As we stated above, this could easily be our next big winner of Q1 2019. We are urging all members to start their research now, and consider grabbing up a position in QBIO tomorrow morning at 9:30AM EST! (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for QBIO. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
OTC:QBIOLong
by RedHotStocks
KNHBF: Could this be the start of the Next +100pct Rally? ===================== Our New Pick is: KNHBF Current Price: $0.25 Investor Presentation ======================== Members, Earlier this week, we told you that we were looking for the perfect trade idea that could deliver easy profits during this brutal bear market. After scanning the market for quite some time, we've decided not to take any chances, and just go with a company that has proven itself to be a winner each and every time we've alerted it to our members. Please turn your immediate to attention back to our #1 cannabis play of 2018 KNHBF (ICC International Cannabis Corp.) We plan on ending this 2019 on a high-note with this past +100% winner! We first brought KNHBF to your attention back on September 27 when it was flying under the radar at just $0.44 per share. In less than two week's time, shares of KNHBF rallied as high as $0.90, representing multi-day gains of up to +104.55% for our members. We are just as excited about KNHBF now as we were back in late September. In fact, the upside is even more attractive now. Shares of KNHBF traded down to $0.25 yesterday, creating the perfect buying opportunity for those looking to cash in on the cannabis boom at a ground floor price. We've been keeping a close eye on this red-hot cannabis play, and we believe that right now could be the perfect entry point for those looking for a piece of this cannabis company committed to growth Here's why... On Oct. 17, Canada becomes the second and largest country with a legal national marijuana marketplace. KNHBF has been issued the FIRST EVER medical cannabis cultivation license by the Greek government. Broke ground on Colombian Centre of Excellence for Cannabis Propagation; Marking Initialization of 10-Hectare Cannabis Park Announced the creation of the world’s first fully electronic cannabis marketplace through a partnership with GreenTree International, the parent company of Amercanex, which operates a secure Electronic Cannabis Market (ECM) called ACExchange. Completed 100% Acquisition of Enigma Unipessoal LDA - a company who controls one of the first hemp licenses issued in Portugal Entered into a definitive agreement to acquire 100 percent of Balkan Cannabis Corp (“Balkan Cannabis”). Balkan Cannabis controls Macedonian medical Cannabis cultivation and extraction licenses, as well as Bulgarian medical Cannabis and hemp cultivation licenses. Increased their European distribution footprint by over 1,300 pharmacies As you can see KNHBF is deeply committed to strengthening its grip on the European cannabis market. With a population twice the size of the US and Canada combined, and a cannabis market still in its relative infancy, Europe presents an enormous opportunity. KNHBF has been dropping big news almost daily, and we would not be surprised if the Company announced another major milestone today. This could be one of your last chances to start a position in KNHBF for a under $1 per share.... That being said, we are urging all members to start their research on this past +100% winner immediately, and be ready to take action this morning at 9:30AM EST! About ICC International Cannabis Corp. Via its diversified portfolio of companies and subsidiaries, ICC International Cannabis intends to further establish itself as a international Cannabis industry consolidation platform. The Company’s mission is to inspire holistic wellness by augmenting the design, development and production of the world’s most innovative and best performing Cannabis products and facilities. Through its subsidiaries, KNHBF has agreements in place for European-based pharmaceutical distribution, wholesale importation, research and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the Kingdom of Lesotho, Africa and Denmark. Company Highlights: 110 clients representing approximately 36,300 pharmacies in 16 countries 13 hectacres of optimal agricultural land dedicated to cannabis cultivation located in Funza, Colombia 16 acres of fertile agricultural land dedicated to industrial cultivation and CBD extractuib siturated within the Greek prefecture of Imathia 2,400 pharmacies included in their distribution portfolio of independent and corporate pharmacies across South Africa 55k sq/ft fully automated IMC-GAP, ISO:9001 and European GMP compliant greenhouse facility to be constructed in Denmark 9 licenses or cultivation, spanning three continents KNHBF's Current Holdings Marathon Global Inc. Marathon Global has an exclusive agreement with Cosmos Holdings, a European based pharmaceutical distributor, to procure and distribute medical cannabis products and all cannabis derivatives for clients of Cosmos in approved countries within its distribution network of 110 clients, representing approximately 35,000 pharmacies in 16 countries. Marathon Global brings an unparalleled ability to supply the overwhelming demand for cannabis and cannabis extracts in Europe as Cosmos brings generations worth of experience and relationship to Kaneh Bosm. This distribution strategy carries on the Company’s existing distribution business through its unique BioCanna ADM retail system. EU Cannabis Corp. EU Cannabis has an option to acquire a 90-per-cent working interest in industrial hemp licenses held by Cannatec Greece A.E. Cannatech currently holds three licenses covering a total of 16 acres situated within the Greek prefecture of Imathia. These licenses were granted to Cannatec by the Hellenic Republic Ministry of Agricultural Development and Food, and permit EU Cannabis to cultivate, manufacture, distribute and export industrial hemp and its many cannabidiol (CBD) derived extracts. Greece boasts over 300 days of unadulterated sunshine per year, resulting in attractive climate for outdoor industrial hemp cultivation. The alignment of the company’s existing distribution channels, revolutionary ADM retail system along with EU Cannabis’s robust extraction capabilities will assist in appeasing an expanding appetite for functional CBD products within the European Union. Danavian Cannabis Ltd. Danavian controls licenses for cannabis cultivation and manufacturing in the Kingdom of Denmark. Kaneh Bosm’s entry into Denmark mirrors industry peers such as Canopy Growth Corporation, Green Organic Dutchman Holdings, Aurora Cannabis Inc. and CannTrust Holdings. Danavian has engaged an Israeli cannabis organic cultivation and management company, Sababa Sciences Inc. (“Sababa Sciences”). Sababa Sciences will provide end-to-end management including the implementation of advanced Israeli agricultural technologies for high quality medical cannabis treatments. Danavian and Sababa Sciences have designed a 55,000 square foot, fully automated greenhouse facility that will meet IMC-GAP, ISO:9001 and European GMP standards. Finished cannabis and cannabis derivatives produced by Danavian will be sold through Denmark’s retail pharmacy network. Danavian holds claim to premier European cannabis assets; domiciled in a jurisdiction with a highly skilled agriculture and manufacturing workforce. Davavian also boasts various industry relationships that will complement future development potential throughout Scandinavia. Continued development of Danavian’s Danish cannabis portfolio will help serve both local and export market demand. Danavian is tactically positioned in immediate proximity to Germany, allowing for direct imports of CBD products, as well as medical cannabis flower. CanAfrica Holdings CanAfrica holds a license to cultivate, manufacture, supply, hold, import, export and transport cannabis and derivative products. The Kingdom of Lesotho, Africa, has an ideal climate for low-cost greenhouse cannabis production. It averages over 300 days of sunshine annually. Lesotho was the first African nation to legalize medical cannabis in 2017. The Company believes that by establishing a presence in Africa, it will extend its current business model and allow the company to produce its own products to push through its unique and substantial European distribution networks and into its award-winning BioCanna ADM automated retail system. Aricannabis Aricannabis works on an exclusive basis with NuCare Health (“NuCare”) to provide Cannabis products to over 2,800 independent and corporate pharmacies across South Africa. NuCare also provides their medical partners with the following: Access to innovative consumer products; Strategic partnerships with key suppliers; Management of channel pressure; and Educational and training resources. The alignment of the Kaneh Bosm’s existing African cultivation capabilities and distribution channels, complemented by these new established marketing and distribution channels will augment the Company’s African seed-to-sale objectives. Cannabis Medical Group SAS Cannabis Medical Group SAS, a Colombian entity that holds licenses to cultivate, produce, hold, sell and export cannabis and cannabis derivatives. Colombia has become a highly sought-after jurisdiction for cannabis cultivation activities as it has a world-leading combination of broad public and private sector acceptance, ideal growing conditions, and a massive addressable market. Cannabis Medical Group previously acquired 13 hectares of optimal agricultural land located in Funza, the heart of the Bogota savanna, which is also one of the safest areas in Colombia. It is conveniently located within a 20-kilometre drive to Bogota’s international airport. The lease on this land has been prepaid for a period of 10 years. BioCanna ADM Retail System The BioCanna ADM retail system is an intelligent automated retail kiosk for the dispensing of Cannabis and related products in both medical and commercial markets. The BioCanna ADM retail system offers a solution to many of the concerns related to controlling access to ensure that only properly identified and qualified clients can obtain marijuana products. With strict regulations in place throughout the North American Cannabis market the BioCanna ADM could offer Cannabis retailers a means to meet and surpass regulated requirements. The BioCanna ADM retail system is unique in this sector as it encompasses the 5 crucial elements identified by Ret. Major Neill Franklin, executive director of LEAP for safe, reliable and successful automated Cannabis retail. Those elements are: Access control (no minors or un-prescribed patients) Purchase volume control (monthly or daily quantity limits) Secure storage of product (climate controlled and theft proof) Transactional oversight by regulators via software monitoring Proven track record in a controlled substance/products environment The proprietary software system, which operates the BioCanna ADM, offers regulatory bodies the ability to dynamically observe transactions in real-time at every Kiosk located within their legal jurisdiction. As you can see KNHBF is well positioned to monetize the cannabis sector from every possible angle! You would be hard pressed to find a company better positioned for growth in this multi billion dollar market than KNHBF. Recent Developments: International Cannabis Increases European Distribution Footprint by Over 1,300 Pharmacies Last week, the Company announced that its exclusive European distribution partner, Cosmos Holdings, Inc. (“Cosmos”), has acquired Greek pharmaceutical wholesaler, Cosmofarm Ltd. (“Cosmofarm”). Established in 1994, Athens based Cosmofarm provides a comprehensive range of pharmaceutical products to over 1,130 pharmacies. Cosmofarm has been authorized and endorsed by Greece’s National Organization for Medicines under Good Distribution Practices to distribute over-the-counter pharmaceuticals, natural and health food supplements, as well as branded and generic medicines. Cosmofarm is equipped with an extensive supplier network of approximately 250 pharmaceutical manufacturers and realized sales of nearly US$14 million for the fiscal year 2017. Cosmofarm is in the process of relocating its operations to a new 32,000 square foot facility, increasing its manufacturing capacities by 2,000%. The facility’s state-of-the-art manufacturing operations include a robotic fulfillment center and will significantly improve Cosmofarm’s scaling and distribution capabilities. Eugene Beukman, chief executive officer and a director of International Cannabis, stated: “International Cannabis applauds the acquisition of Cosmofarm, which further augments the Company’s robust European distribution capabilities. Cosmofarm is a rapidly growing wholesaler with embedded shared-values of innovation and high-quality distribution. This transaction is once again demonstrative of International Cannabis’ mandate of creating sustainable shareholder value, through the strategic acquisition of revenue generating assets. The Company will leverage Cosmofarm’s distribution channels and robotic fulfillment centre to facilitate its growing pipeline of purchase orders in 2019”. International Cannabis will market and sell its cannabis and cannabidiol (“CBD”) products throughout the 28 eligible member states of the European Union (“EU”). The EU has over 500 million potential consumers, affording International Cannabis a unique opportunity to service this high-growth marketplace. Furthermore, the Company plans further leverage Cosmofarm’s 32,000 square foot facility to manufacture and distribute white-labeled CBD products from its Greek industrial hemp cultivation operations. International Cannabis controls three hemp licenses spanning a total of 16 acres situated within the Greek prefecture of Imathia. These licenses permit the Company cultivate, manufacture, distribute and export industrial hemp and its many CBD derived extracts. Greece boasts over 300 days of unadulterated sunshine per year, resulting in attractive climate for outdoor industrial hemp cultivation. International Cannabis will leverage Cosmos Holdings Inc.'s robust distribution network, representing approximately 36,130 pharmacies to market and sell its cannabis and CBD products. The Company, through its wholly owned subsidiary Marathon Global Inc., has an exclusive agreement with Cosmos, a European-based pharmaceutical distributor. Cosmos has a trans-European network of over 160 clients and vendors, which expands to 16 countries, including: Germany, United Kingdom, Ireland, United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, the Netherlands and Greece. This European distribution network is augmented by various value-added services, including strategic procurement, warehousing, product registrations and regulatory representations. International Cannabis, through its subsidiaries, has agreements in place for European-based pharmaceutical distribution, wholesale importation, and research and development, as well as licenses to cultivate, produce, distribute, store and export cannabis, cannabis derivatives and industrial hemp in Colombia, Denmark, Poland, Greece, Portugal, Poland, Macedonia, Bulgaria, South Africa and the Kingdom of Lesotho. Market Outlook Marijuana: A $75 Billion Market by 2030? This investment bank just increased its sales forecast for the cannabis industry by 50%. It's also a market that's expected to see continued robust sales growth. ArcView pegged North American legal-weed growth at 33% last year, to $9.7 billion, and it's forecasted $47 billion in annual sales in a decade's time. Yet even this aggressive estimate may undercut the true potential of the cannabis industry. The hemp-derived CBD market is forecast to be especially lucrative, and a 2017 report by Brightfield Group – a cannabis & CBD market research organization – predicted a per annum increase of 55% over the next five years alone. The Marijuana Industry Could be Much Bigger Than You Realize According to a new note published this past week by investment firm Cowen, the total cannabis market could generate as much as $75 billion in gross annual sales by 2030, up from a previous forecast of $50 billion by 2026. The investment bank's initial forecast was released in September 2016 via a 110-page report from beverage, tobacco, and cannabis sector analyst Vivien Azer and her team. The report, "The Cannabis Compendium: Cross-Sector Views on a Budding Industry," highlighted the many potential applications of legal cannabis and outlined pathways that would allow the weed industry to reach $50 billion in sales by 2026. Chief to that thesis is the expected legalization of marijuana in the U.S. at some point before 2026. The investment bank's new note lifts its projected sales estimate by another 50% ($25 billion), while adding on just four additional years. Cowen offered six reasons behind its decision to become even more bullish on the outlook for marijuana. Chief among them was proprietary data on binge-drinking statistics among U.S. states that showed a notable decline in binge drinking below the national average in states that had legalized cannabis. It's Cowen's assumption that as more states legalize pot, binge-drinking rates would be expected to fall as consumers opt for cannabis in place of alcohol. Additionally, Cowen finds that the cannabis market is already worth about $50 billion, albeit with black-market channels being accounted for. If you factor in per-capita spending of $1,500 a year, 50% higher than it previously forecast, along with 35 million annual cannabis users, you can see where the bulk of this $25 billion annual increase from its 2016 projections is coming from. Cowen even suggests that the United States' fight against the opioid epidemic could lead to an increase in cannabis consumption. Per the report, "Newly published research reinforces the work that we have already done, showing that for some, cannabis is an effective opioid substitute (in particular in treating chronic pain)." Technical Analysis KNHBF has never looked more attractive. Yesterday's ten percent drop in price just created the ultimate "buy the dip" opportunity for our members. KNHBF's RSI is hovering just above oversold levels, and we believe that a major bullish reversal is in the making. We also know how fast this stock can move from first hand experience. When we last brought it to your attention, shares of KNHBF made intraday swings as high as +57.39%! A run back to its 52-week of $0.90 would show our members up to +260% in pure profit! Don't miss out on KNHBF's next potential +100% rally! This is our last trade idea of 2018! And we plan on ending the year on a high note. As such, we are urging all members to act fast, start their research on KNHBF, and be ready to take action at 9:30AM EST! (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The PennyStock101 Team Don't Miss Our Next Huge Winner... Text 'PS101' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by ICC International Cannabis Corp. to conduct investor relations advertising and marketing for KNHBF. We have been previously compensated ten thousand dollars by ICC International Cannabis Corp. to conduct investor relations advertising and marketing for KNHBF-which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
KLong
by RedHotStocks
Metronome - 14mm usd cap "Gem" with Bitcoin Core Dev CreatorMetronome (www.metronome.io) is a built to last cryptocurrency originally created by Bloq, headed by Jeff Garzik (core bitcoin developer). It has a unique auction mechanism that controls inflation of the money supply and built in converter contracts that provide liquidity in wallet in either direction (think a mini bancor). The converter contract currently has ~4000 eth of buyside liquidity and 500k metronome in sellside liquidity. This liquidity shifts based on the day's auction price. Metronome is self governing and portable... meaning that users will soon be able to move their tokens in between blockchains. Because of this, metronome will survive forever. Metronome is intended as a store of value. From a technical perspective, we can see that Metronome has broken its horizontal range. I believe this project is extremely undervalued from a fundamental perspective and am targeting 100million -250million usd market cap to sell. Idex seems to be the most liquid place to purchase, but it's available in the Metronome wallet as well as Bittrex and other exchanges. DYOR and feel free to join their telegram. They are very helpful.
MLong
by LARP_Capital
MNKD - Next Resistance Level 1.5, or Reversal of DownTrendLooking for a resistance level that causes a reversal of trend. You can see the 2.01 resistance level was hit on 9/6, and 9/7 the price fell through to 1.78. If the downward trend continues, the next resistance level to be hit would be 1.5. Substantial sell volume on 9/5, 9/6 and 9/7 could be indicative of a higher likelihood for a trend reversal early next week. According to Chris Lau at InvestorPlace, a 10 yr discounted cash flow revenue exit model values shares at an average of $2.40, placing the stock at a current discount of 20/25%, assuming revenue increases due to the new partnership with UTHR. finance.yahoo.com
NASDAQ:MNKDLong
by intelitrades
The most important chart in Bitcoin: Metcalfe's lawSorry, I didn't know how to do it here on tradingview. My very smart girlfriend Jixuan Wang used the program R to import and plot the real bitcoin price versus the Metcalfe price: ibb.co Orange is real price from exchanges, green is Metcalfe price, which can be calculated from the number of the daily transactions squared: P = C* T². P=price C= a constant, chosen such that the fit is good T = number of daily transactions If orange above green: BTC IS OVERPRICED If green above orange: BTC IS UNDERPRICED We are currently overpriced, same as in 2014/2015. This is one of the main reasons why I believe that this bearmarket will still go on for 1 more year.
BITFINEX:BTCUSD
by SebastianofMoon
6
Pundi X - NPXSBTC - Daily ChartIn my honest opinion Pundi X or NPXS/BTC is undervalued. As its being deployed in over 12 countries with more than 100,000 XPOS devices. Pundi X has a real world application and promotes the use of buying and selling crypto which is a plus. They are targeting stores pundix.com "Pundi X’s mission is to make buying cryptocurrency as easy as buying bottled water. As the Walmart and 7-Eleven of cryptocurrency, we want users to buy and use cryptocurrency anytime anywhere." Pundi XPOS solutions Digitalizing any physical stores. Buy cryptocurrency using fiat, bank card, mobile wallet or Pundi XPASS. CoinMarketCap - coinmarketcap.com Price as of 8/4/18 $0.001987 USD (3.34%) 0.00000028 BTC (9.42%) 0.00000486 ETH (5.62%) Market Cap $195,866,108 USD 27,913 BTC 478,975 ETH Volume (24h) $6,603,870 USD 941.14 BTC 16,149 ETH Circulating Supply 98,575,582,989 NPXS Total Supply 280,755,195,000 NPXS
NLong
by CointheCrypto
Anyone want to buy a multi billion dollar company? (investment)People at the head of the company been accused of fraud? Irrelevant. All I see is a multi billion conglomerate that got panic sold and still is functionning as it was before. No one is interested in this, it got abandonned. Yet, they're still the same nothing has changed. People only care about something when (after) it goes up and there's no FUD around it. If there is a big green candle people will invest in anything, even magical internet monopoly money that doesn't work only has problems and is a solution to nothing, and which only fundamental value is people's greed. This is the best time to get in a company. There's always a risk it goes bankrupt, but no one gets rewarded for not taking risks, it's like a law of the universe. And the reward here is just INSANE. Who tf is even selling at that price? People that bough after it crashed?Hope there's more FUD and the stock drops even lower in the next months. But looks like it could be moving out of accumulation zone now... I'll miss out :( They have some meeting in the next hours, let's see what happens then. +++ I have no idea what I am doing +++
SLong
by MrRenev
[IOST-BTC] IOSTOKEN 25-50% ROI-OPPORTUNITYAs I stated in this video, Jimmy Zhong co-founder of this token is a freak-in young genius. Not only am I excited about the fundamentals for a long time now on this token , but I like what I see on my TA now! This token or crypto is so undervalued. I always focus on undervalued cryptos. It's not all about the major top 25 coins. There are gems and diamonds out there if you can actually find them. Below you will find multiple links as fundamental analysis research if you know absolutely nothing about this token! Thanks for your recent support on my last video. We had about 30 subscribers jump in and follow me just from my last TRON (TRX) TA.. If you enjoyed my TA here, then please comment, and like this video and join my channel here on trading view! As I mentioned on this video, I will be loading up more on this token for sure! I also will start trading IOST even though I generally consider this volume to still be kind of low and out of my parameters in terms of minimum 24hr volume which is what I generally look for in trading altcoins. This token is starting to have more volatility and increased 24hr volume which to me starts making it a trade-able crypto token! PS. Full Disclosure: This is not financial advice, this TA is only for educational purposes. You must perform your own research, investing in crypto is risky and volatile. You are responsible for your own actions! Thanks, your aspiring trader/crypto analyst CryptoBuzzAnalyst coinmarketcap.com iost.io twitter.com www.youtube.com
ILong
by CryptoBuzzAnalyst
2
$LINK Nearing Breakout Level - Strong Buy$LINK (ChainLink) is an undervalued project I have been monitoring for the past few months. Chainlink is the only project focusing on being a decentralized oracle provider that has a MASSIVE use case, partnerships like Request Network, ZeppelinOS, SWIFT and the LINK token can be staked in pools in the future to provide passive income. Initial Entry - 5175 Sats ($0.49) Analysis: - Long-term Descending Triangle Broken (Red) - Ascending Triangle Nearing Breakout Level (Green) Breakout Level: 6175 Sats ($0.59) Target 1 : 6928 Sats (33.6%) Target 2 : 7681 Sats (67.3%) Target 3 : 9187 Sats (134.6%)
by isandhir
Book Value: $3.72 (Total Shareholder's equity/number of shares)We know...Market doesn't follow any logic. Finally the super overvalued stocks are starting fo fall . Anyway, there are very few stocks which are quite undervalued. Benjamin Graham’s Criteria for Picking Value Stocks VALUE CRITERIAS: Graham advised buying companies with Total Debt to Current Asset ratios of less than 1.10 - ODP Current Assets (in millions) 2,870 ODP Total Debt is 1,700. so 1700/2870 = 0.59 (Much less than 1.10) Current Ratio (current assets divided by current liabilities) to find companies with ratios over 1.50. About OFFICE Depot Numbers: 2870/2046 = 1.40 (a bit lower than 1.50) Invest in companies with price to earnings per share (P/E) ratios of 9.0 or less. ODP P/E is 6.8 Find companies with price to book value (P/BV) ratios less than 1.20. ODP Price (Market value) is 1,280 . Total stockholders’ equity (last quarter) is 2,120 so 1,280/2,120 = 0,6 (50% less than 1.20!) Invest in companies that are currently paying dividends. ODP, actually, is paying dividends. Following the Graham numbers, ODP is one of the very very few companies to be undervalued. It's undervalued by 76% dqydj.com
NASDAQ:ODP
by giloc